Semaglutide: The active ingredient in Ozempic and Wegovy, used for type 2 diabetes and, at higher doses, chronic weight management
Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG
In 2025, increased clinical success of oral GLP-1 drugs for weight loss and broader approvals by regulatory bodies have driven demand among individuals seeking non-invasive, effective obesity treatment options
Trusted by Professionals: Widely recommended by dermatologists worldwide
Its origin story is a huge clue to its primary function: protection and repair
It has been demonstrated that both Parkin and PINK1 are involved in the regulation of mitophagy